Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

ClinicalTrials.gov ID: NCT03448692

Public ClinicalTrials.gov record NCT03448692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2, 24-WEEK, ADAPTIVE, OPEN LABEL, SEQUENTIAL COHORT TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06730512 FOLLOWING MULTIPLE DOSES IN ADULT SUBJECTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

Study identification

NCT ID
NCT03448692
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
47 participants

Conditions and interventions

Interventions

  • PF-06730512 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2018
Primary completion
Feb 13, 2023
Completion
Feb 13, 2023
Last update posted
Apr 17, 2024

2018 – 2023

United States locations

U.S. sites
56
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
The Kirklin Clinic of University Alabama Birmingham Hospital Birmingham Alabama 35233
Investigational Drug Service Pharmacy UAB Hosptial Birmingham Alabama 35249
Clinical Research Unit at UAB Hospital Birmingham Alabama 35294
UAB Nephrology Research Clinic at Paula Building Birmingham Alabama 35294
Academic Medical Research Institute Los Angeles California 90022
Cedars Sinai Medical Center Los Angeles California 90048
Cedars-Sinai Ambulatory Infusion Center Los Angeles California 90048
Cedars-Sinai Comprehensive Transplant Center Los Angeles California 90048
Ronald Reagan UCLA Medical Center Los Angeles California 90095
UCLA Clinical and Translational Research Center Los Angeles California 90095
UCLA Department of Medicine Los Angeles California 90095
Clinical and Translation Research Unit Palo Alto California 94304
Stanford University-Nephrology Division Palo Alto California 94304
University of California, San Francisco San Francisco California 94143
Stanford Health Care Investigational Pharmacy Stanford California 94305
Stanford University-Nephrology Division Stanford California 94305
Stanford University Stanford California 94305
Yale Center for Clinical Investigation Hospital Research Unit New Haven Connecticut 06510
Yale Nephrology Clinical Research Clinic New Haven Connecticut 06510
Yale University School of Medicine - Yale-New Haven Hospital New Haven Connecticut 06510
Yale University New Haven Connecticut 06510
Yale New Haven Hospital New Haven Connecticut 06511
Yale Center for Clinical Investigation - Church Street Research Unit New Haven Connecticut 06519
University of Miami Hospital and Clinics Miami Florida 33136
University of Miami Katz Family Division of Nephrology Miami Florida 33136
University of Miami Miami Florida 33136
Georgia Nephrology Research Institute Lawrenceville Georgia 30046
Georgia Nephrology Lawrenceville Georgia 30046
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Johnson County Clin Trials Lenexa Kansas 66219
Boston Medical Center - Interventional Radiology Boston Massachusetts 02118
Boston Medical Center - Nephrology Boston Massachusetts 02118
Boston Medical Center Boston Massachusetts 02118
Boston University - GCRU Boston Massachusetts 02118
Henry Ford Hospital Detroit Michigan 48202
Clinical Research Consultants, LLC Kansas City Missouri 64111
St. Luke's Hospital Kansas City Missouri 64111
New York University Grossman School of Medicine - CTSI New York New York 10016
UNC Eastowne Chapel Hill North Carolina 27514
UNC Clinical and Translational Research Center Chapel Hill North Carolina 27599-7064
University of Cincinnati at DCI McMillan Research Unit Cincinnati Ohio 45206
Hoxworth Center Subspecialties Clinic Cincinnati Ohio 45219
UC Health Barrett Center Cincinnati Ohio 45219
UC Health Medical Arts Building Cincinnati Ohio 45219
University of Cincinnati Gardner Neuroscience Institute Cincinnati Ohio 45229
The Cleveland Clinic - Investigational Drug Pharmacy Cleveland Ohio 44195
The Cleveland Clinic Cleveland Ohio 44195
CarePoint East at The Ohio State University Columbus Ohio 43203
The Ohio State University Clinical Research Center Columbus Ohio 43210
The Ohio State University Investigational Drug Services Columbus Ohio 43210
The Ohio State University Wexner Medical Center- Nephrology Clinical Trials Unit Columbus Ohio 43210
The Ohio State University Columbus Ohio 43210
Kidney and Hypertension Care Center, PA Houston Texas 77004
Southside Pharmacy Houston Texas 77030
Prolato Clinical Research Center (PCRC) Houston Texas 77054
Baylor Scott & White Clinic - Temple South Loop Temple Texas 76502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03448692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2024 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03448692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →